Skip Navigation

Who we are

Thomas Wichmann, M.D.
Director of the Emory Udall Center
Key scientist, Project 2: Parkinsonism-Related Changes in Activity of Cortical Projection Neurons in Monkeys

WichmannDr. Wichmann attended medical school in Freiburg (Germany) and received his medical degree in 1984.  This was followed by postdoctoral medical and research training in Germany and at Johns Hopkins University (Baltimore, MD), and internship and Neurology residency training at Emory University (Atlanta, GA).  He has been a member of the movement disorder division in the Dept. of Neurology at Emory University since 1996.  He is currently a Professor of Neurology, and serves as the Associate Director of the movement disorder clinic at Emory.  His research focuses on electrophysiological and morphological changes in Parkinson’s disease, with the aim of developing new pharmacological or surgical interventions to help parkinsonian patients.  To learn more about Dr. Wichmann's research team, click here.

Dieter Jaeger, Ph.D.
Lead scientist, Project 1: Cortical Connectivity and Activity Changes in Motor Preparation and Execution in 6-OHDA-Lesioned Mice

DieterDieter Jaeger received his college education with a specialization in Biochemistry in Tübingen, Germany. He joined the PhD program in neuroscience at the University of Michigan in 1984. His dissertation research investigated the function of the basal ganglia in behaving primates. Dr. Jaeger joined the California Institute of Technology as postdoctoral fellow in 1991, and pursued research in computer modeling and electrical recordings of single neurons. Dr. Jaeger joined the faculty of the Department of Biology at Emory University in 1997 and now is a full professor there. Dr. Jaeger also serves as the Director of the Emory / Georgia Tech NIH Blueprint training program in computational neuroscienceHis research is concerned with the single neuron and network function of basal ganglia and cerebellar brain structures. He combines methods of computer modeling with electrophysiological investigations.  To learn more about Dr. Jaeger's research team, click here.

Adriana Galvan, Ph.D.
Lead scientist, Project 2: Parkinsonism-Related Changes in Activity of Cortical Projection Neurons in Monkeys
Director, Core B: Research Services Core

Adriana GalvanAdriana Galvan received her PhD in Neurosciences from the Center of Research and Advanced Studies, National Polytechnic Institute, Mexico City, Mexico. She joined the labs of Drs. Smith and Wichmann in 2000, as a post-doc fellow, to study localization and functions of GABA receptors in monkeys. In 2009 she joined the Department of Neurology as junior faculty member.  Her research focuses on understanding neural transmission in the basal ganglia, both in normal and pathological conditions, using a variety of in vivo methodologies that include extracellular electrophysiological recordings, electrical stimulation, intracerebral microinjections, microdialysis and optogenetic technique.  To learn more about Dr. Galvan's research team, click here.

Yoland Smith, Ph.D.
Lead Scientist, Project 3: Connectome of Motor Corticofugal Neurons in Parkinsonian Monkeys

Yoland SmithYoland Smith received his PhD degree in Neurobiology from Laval University, Quebec, Canada in 1988. Through the use of immunocytochemistry and tract-tracing methods, he published series of manuscripts that contributed significantly to our current knowledge of the circuitry and chemical anatomy of the primate basal ganglia. He then spent two years of postdoctoral training at the MRC Unit in Oxford, where he learned various electron microscopy techniques that he used to elucidate various aspects of the synaptic microcircuitry of the basal ganglia. He then joined the faculty in the Department of Anatomy of Laval University in Quebec where he spent five years (1991-1996) developing a research program that focused primarily on the synaptic organization of the primate basal ganglia. In 1996, Dr. Smith moved to the Yerkes National Primate Research Center at Emory, where his research program includes of a multidisciplinary team that uses techniques in neuroanatomy, electrophysiology and behavioral pharmacology to study the synaptic microcircuitry and plasticity of GABA and glutamate systems in the basal ganglia of normal monkeys and animal models of Parkinson's disease.  To learn more about Dr. Smith's research team, click here.

Svjetlana Miocinovic, M.D., Ph.D.
Lead Scientist, Project 4: Cortical Electrophysiology of Response Inhibition and Implications for DBS Therapy in Patients

Svjetlana MiocinovicSvjetlana Miocinovic is a board-certified neurologist specializing in Parkinsons disease, dystonia, tremor and other movement disorders. She graduated from medical school in 2009 at Case Western Reserve University (Cleveland, Ohio) where she also obtained a PhD in biomedical engineering. She completed neurology residency and clinical movement disorders fellowship at University of Texas Southwestern Medical Center (Dallas, Texas). Her post-doctoral training and clinical research fellowship was at the University of California San Francisco Movement Disorder and Neuromodulation Center. She was awarded American Brain Foundation and Dystonia Medical Research Foundation grants to study electrophysiology of movement disorders and the effects of deep brain stimulation (DBS) on the basal ganglia and cortical circuitry. In 2016, she moved to Emory to become an Assistant Professor in the Department of Neurology, Movement Disorders Section. She received NIH K23 grant to study targeted activation of neural pathways during DBS in Parkinsons disease. The research focus of her laboratory is on electrophysiology of human motor circuits, and development of new device-based therapies. Her clinical focus is on delivering expert patient care and using DBS to treat movement disorders. To learn more about Dr. Miocinovic's research team, click here.

Stewart Factor, D.O.
Director, Core C: Clinical Core

Stewart FactorStewart Factor is the director of the movement disorder program at Emory University. His primary areas of interest and research activities have been the study of movement disorder phenomenology, clinical trials in Parkinsons disease (PD), Huntingtons disease and dystonia and study of genetics, environmental exposures and biomarkers in PD. He is the site PI for the Parkinsons Progression Markers Initiative (PPMI) supported by the Michael J Fox Foundation. He is currently examining in a longitudinal fashion psychiatric and cognitive outcomes in PD. To learn more about Dr. Factor's research team, click here.